Legislative Activity

This bill, the Pharmacists Fight Back in Federal Employee Health Benefit Plans Act, establishes new rules for Pharmacy Benefit Managers (PBMs) administering prescription drug benefits for federal employees. It mandates specific reimbursement rates for pharmacies and prohibits PBMs from engaging in anti-competitive practices like steering patients to affiliated pharmacies. The legislation also institutes civil monetary penalties and potential debarment for PBMs that fail to comply with these new requirements.

The Alzheimer’s Early Detection Act of 2026 mandates that private health insurance plans and Medicaid provide comprehensive coverage for Alzheimer’s biomarker testing. By prohibiting restrictive cost-sharing, step therapy, and lengthy authorization delays, the bill aims to ensure equitable and timely access to essential diagnostic tools. Additionally, the Act requires the NIH to conduct ongoing studies to evaluate the clinical value of these tests in the detection and management of Alzheimer’s disease.

The Hot Rock Act establishes a comprehensive federal program to accelerate the research, development, and demonstration of next-generation geothermal energy projects utilizing hot dry rock resources. It authorizes significant funding for research grants, the construction of a frontier testing site, and risk-sharing for commercial deployment. Furthermore, the bill supports workforce transition for oil and gas workers and streamlines environmental reviews for geothermal exploration on federal lands.

This bill amends the Employee Retirement Income Security Act (ERISA) to classify pharmacy benefit managers (PBMs) as fiduciaries when they manage prescription drug networks, formularies, or claims. It mandates increased transparency by requiring PBMs and third-party administrators to disclose all direct and indirect compensation. Additionally, the legislation prohibits PBMs from being indemnified against liability for fiduciary breaches, ensuring greater accountability in the management of health plan benefits.

This bill establishes new federal requirements for Pharmacy Benefit Managers (PBMs) contracting with Medicare Part D and Medicaid plans, effective in 2027. It mandates specific payment standards for pharmacies, requires PBMs to pass manufacturer rebates directly to patients and plan sponsors, and strictly prohibits steering patients toward specific pharmacies. Additionally, the legislation enhances transparency by expanding drug price reporting requirements for all types of pharmacies within the Medicaid program.

The Deepfake Liability Act amends Section 230 to impose a duty of care on online platforms regarding cyberstalking and intimate privacy violations, including nonconsensual deepfakes. This protection is conditional on platforms implementing reasonable processes for prevention, data logging, and content removal. The bill also strengthens the TAKE IT DOWN Act by expanding its notice and removal process to cover these specific violations within 48 hours.

The Education Not Endless Scrolling Act imposes a new federal tax on large digital advertising companies to fund dedicated trust funds. These funds are earmarked to support local journalism preservation and establish a new grant program for one-on-one student tutoring. Additionally, the revenue will automatically support existing Career and Technical Education programs.

The Parents Over Platforms Act establishes new responsibilities for application distributors and developers to protect minors online. This includes requiring age declaration, providing mechanisms for age assurance, and restricting personalized advertising to minors. Violations of the Act will be enforced by the Federal Trade Commission as an unfair or deceptive practice.

This bill, the ACA Copay CAP Act of 2025, amends the Affordable Care Act to establish a firm annual out-of-pocket spending limit for prescription drugs, beginning in 2027. It sets this cap at $2,000 for self-only coverage, and double that amount for family coverage. Once this limit is met, individuals will no longer face cost-sharing for prescription drugs for the remainder of the plan year.

The Power of the Mint Act asserts Congress's constitutional authority over the nation's money supply. This bill strictly prohibits the Federal Reserve and the Treasury Department from issuing a central bank digital currency (CBDC) unless explicitly authorized by Congress. It ensures that any digital dollar remains a direct liability of the Federal Reserve, subject to legislative approval.

The Supporting Transit Commutes Act allows employers to claim tax deductions for providing qualified transportation fringe benefits, such as transit passes, to their employees. This legislation aims to incentivize the use of public transit by making it more cost-effective for businesses to offer commuting support.